ALAMEDA, Calif., Aug. 21, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 2019 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, September 4, 2019. 

CHICAGO, Aug. 21, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the 17th Annual Morgan Stanley Global Healthcare Conference on Monday, September 9, 2019, in New York. John Groetelaars, Hillrom's president and chief executive officer,

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Flume Health Inc., a digital health plan administrator, announced today that Joel Pitt has joined the company as Vice President of National Sales. He will be responsible for new client acquisition and new plan development.

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Partnership for Drug-Free Kids has launched two campaigns that examine the impact of opioid addiction on families, while offering h

WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- Today, the Smarter Health Care Coalition, a multi-stakeholder coalition representing consumer organizations, employer groups, health plans, life science companies, provider-related organizations, academic centers, and foundations, advocated for the Secretary of Health and Human Services (HHS) to expand the scope of value-bas

BOONE, N.C., Aug. 21, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors.

GALVESTON, Texas, Aug. 21, 2019 /PRNewswire/ -- Chrysalis BioTherapeutics, Inc. today announced that the US Food and Drug Administration (FDA) Office of Orphan Product Development and the European Medicines Agency (EMA) have granted Orphan Drug Designation (ODD) to the company's lead compound, TP508 (rusalatide acetate) for the treatment of acute radiation syndrome

TOKYO and NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application

PARAMUS, N.J., Aug. 21, 2019 /PRNewswire/ -- Steve White, CEO of Harvest Health & Recreation, will deliver a Keynote Address, entitled: "Doing Well by Doing Good," at the 6th Annual

COLORADO SPRINGS, Colo., Aug. 21, 2019 /PRNewswire/ -- Break the Silence Against Domestic Violence's 2019 Angel Fund made the biggest impact yet. Bereaved families ac